Biden Admin via CDC Mandates mRNA Vaccination for 6-Month-Old Babies as Requirement of Entry for Immigrants, Migrants or Refugees
https://www.trialsitenews.com/a/biden-admin-via-cdc-mandates-mrna-vaccination-for-6-month-old-babies-as-requirement-of-entry-for-immigrants-migrants-or-refugees-559d46fa
This summer, the U.S. government under the Biden presidency changed specific technical requirements requiring all immigrants and refugees entering the country to prove COVID-19 vaccination. This includes babies as young as 6-month-old. Under the Biden administration, the World Health Organization (WHO) International Health Regulations (IHR) determine the status of health emergencies, triggering domestic laws which prompt executive branch agencies to action, including rulemaking and associated technical requirements of all sorts. The new requirements are found in the Centers for Disease Control and Prevention (CDC) titled “CDC Requirements for Immigrant Medical examinations: COVID-19 Technical Instructions for Panel Physicians;” the stated goal is “Immigrant, Refugee and Migrant Health.” Because few countries vaccinate babies as young as 6-month-old against SARS-CoV-2, the youngest immigrants, migrants, or refugees entering America will need to be inoculated with BNT162b2, the Pfizer-BioNTech vaccine available for young persons, as young as 6-months old.
A Higher Authority
First, it’s important to understand that this new requirement of entry is based on the fact that the U.S. defers to the WHO determination of health emergency via the International Health Regulations framework. The CDC shares on their website:
“The current pandemic of Coronavirus Disease 2019 (COVID-19) has been determined by the World Health Organization (WHO) to be a public health emergency of international concern (PHEIC) under the International Health Regulations. COVID-19 meets the definition of a quarantinable communicable disease under 42 USC 264 and Executive Order 13295, as amended by Executive Order 13375 and 13674. Specifically, COVID-19 meets the definition of severe acute respiratory syndromes as specified by Presidential Executive Order 13674 (issued July 31, 2014), thus making it a Class A Inadmissible Condition.”
The new requirements were activated on July 25th as stated:
"Effective July 25, 2022, the lower age limit for the COVID-19 vaccine requirement is 6 months of age. Any applicant 6 months through 4 years of age who presents for a medical examination on or after this date will be subject to this requirement. See below for additional details. This is in addition to older applicants who are already subject to these requirements."
“If an applicant refuses one or more doses of a COVID-19 vaccine series that is medically appropriate for the applicant, it should be documented that the vaccine requirements are not complete and that the applicant refuses vaccination. This applicant is Class A and is inadmissible to the United States."
The government apparently carved out a possible exemption for adoptees requests.
Who does this rule apply to?
Any “Applicants” that are defined as “people applying for immigrant or refugee status, as well as non-immigrants (NIVs) who are required to have an overseas medical examination, are medically screened days or weeks prior to travel to the United States (US).
Importantly, the CDC elaborates that “a negative screening for COVID-19 at the time of medical evaluation does not guarantee the applicant will not have COVID-19 at the time of immigration to the United States.”
Assumption: Vaccination Controls Spread of COVID
Underlying this Biden administration policy is the explicit assumption that vaccination becomes a keyway to control the spread of SARS-CoV-2, along with other means including “strategic testing” and “Routine infection control practices.”
Yet it’s well known that with ongoing mutation the current COVID-19 vaccines don’t stop the transmission of COVID-19, although they have been shown to reduce serious infection and hospitalization. Especially earlier on with the Wuhan, and other strains that were closer to the first “Wild Type” strain of SARS-CoV-2.
But even the protection against more serious disease has strained with Omicron. Of course, the FDA and CDC just gave both Pfizer-BioNTech and Moderna the greenlight for their BA.5 bivalent products less human data—Biden’s health authorities have determined that the urgency of the pandemic necessitates the accelerated delivery of the countermeasures to the population.
p1